PUBLISHER: The Insight Partners | PRODUCT CODE: 2166004
PUBLISHER: The Insight Partners | PRODUCT CODE: 2166004
The South and Central America Automated Peritoneal Dialysis Market is expected to increase from US$ 29.8 Million in 2025 to US$ 39.7 Million by 2034. The market is projected to register a CAGR of 3.3% between 2026 and 2034.
Executive Summary and South and Central America Automated Peritoneal Dialysis Market Analysis
The South & Central America automated peritoneal dialysis market is witnessing gradual expansion, supported by the growing prevalence of chronic kidney disease (CKD), improved availability of renal replacement therapies, and government-led initiatives aimed at increasing access to home dialysis. According to updates from the Pan American Health Organization covering 2023-2025, noncommunicable diseases, including CKD, accounted for more than 80% of deaths across Latin America. This substantial disease burden is increasing the number of patients progressing toward kidney failure and subsequently requiring dialysis.
Data from the Latin American Dialysis and Transplant Registry also indicates that access to kidney replacement therapy has expanded considerably throughout Latin America. Peritoneal dialysis is increasingly being incorporated into national renal care strategies, particularly in countries seeking to improve treatment access for patients living in rural and geographically remote areas.
Governments across the region are promoting home-based dialysis approaches to reduce congestion at urban dialysis centers, improve healthcare resource utilization, and support patient quality of life. Technological developments, including portable automated peritoneal dialysis cyclers and remote monitoring systems, are further improving the feasibility of home treatment, especially for populations distributed across large geographic areas.
Increasing investment in healthcare infrastructure, greater awareness of CKD screening and treatment, and regional collaboration focused on nephrology education and professional training are also contributing to improved access to dialysis services. Collectively, these developments are supporting the continued adoption of APD across South and Central America.
Strategic Insights
South and Central America Automated Peritoneal Dialysis Market Segmentation Analysis
By Product Type, the South and Central America Automated Peritoneal Dialysis Market is segmented into Peritoneal Dialysis Solution, Peritoneal Dialysis Catheters, Peritoneal Dialysis Transfer Sets, and Others. The Peritoneal Dialysis Solution segment dominated the market in 2025.
By End User, the South and Central America Automated Peritoneal Dialysis Market is divided into In-Center Dialysis Settings and Home Care Settings. The In-Center Dialysis Settings segment accounted for the largest market share in 2025.
Market Report Scope
South and Central America Automated Peritoneal Dialysis Market Outlook
Expanding access to automated peritoneal dialysis in emerging and underserved healthcare systems represents a significant growth opportunity, particularly as the prevalence of chronic kidney disease and kidney failure requiring replacement therapy continues to rise. Globally, approximately 788 million adults aged over 20 years were estimated to be living with CKD in 2023. The growing burden is associated with population aging, increasing rates of diabetes and hypertension, and improvements in disease detection across both developed and developing healthcare systems.
Although government registries do not consistently provide APD-specific prevalence figures, broader dialysis statistics and peritoneal dialysis trends indicate considerable unmet treatment requirements in regions where in-center hemodialysis infrastructure is limited. Global estimates suggest that approximately 4.59 million people required kidney failure replacement therapy (KFRT) in 2023, demonstrating the substantial and continuing demand for renal replacement services that extended into 2024 and 2025.
In countries where conventional in-center hemodialysis facilities are limited, expensive, or concentrated in major cities, APD provides a practical home-based alternative that can reduce dependence on hospitals and support broader universal health coverage objectives. PD modalities, including APD, are also gaining attention in emerging markets where healthcare authorities are investing in ambulatory care models, home treatment infrastructure, and dialysis training programs.
Expanding APD in these markets can help address treatment gaps, decentralize renal care delivery, and reduce pressure on tertiary hospitals and dialysis centers. Partnerships among medical device manufacturers, government healthcare organizations, and non-governmental organizations can further accelerate adoption by improving patient and clinician training, strengthening supply chain networks, and supporting reimbursement and financing reforms.
South and Central America Automated Peritoneal Dialysis Market Country Insights
By country, the South and Central America Automated Peritoneal Dialysis Market is segmented into Brazil, Argentina, and the Rest of South and Central America. Brazil accounted for the largest market share in 2025.
The Brazil automated peritoneal dialysis market is expanding due to the country's substantial dialysis population, increasing CKD prevalence, and broad public healthcare coverage for renal replacement treatments. According to the Brazilian Society of Nephrology 2023 Dialysis Census, more than 160,000 people in Brazil were receiving chronic dialysis, representing one of the largest dialysis populations in Latin America. This sizable patient base creates significant demand for a broad range of dialysis options, including peritoneal dialysis and automated peritoneal dialysis.
Brazil's public healthcare system, Sistema Unico de Saude (SUS), provides coverage for dialysis services, improving treatment accessibility and supporting greater consideration of home-based renal replacement therapies. National nephrology data also indicate increasing efforts to expand peritoneal dialysis programs, particularly in areas where dependence on in-center hemodialysis creates challenges for patients and healthcare facilities.
Technological improvements, including automated cyclers equipped with enhanced safety functions and remote monitoring capabilities, are improving the convenience, adherence, and clinical management of APD. At the same time, the rising prevalence of diabetes and hypertension is contributing to an expanding population at risk of kidney failure.
The combination of supportive reimbursement mechanisms, increasing awareness of home dialysis advantages, technological development, and continued strengthening of nephrology services is expected to support sustained growth of the automated peritoneal dialysis market in Brazil.
South and Central America Automated Peritoneal Dialysis Market Company Profiles
Major companies operating in the South and Central America Automated Peritoneal Dialysis Market include Terumo Corp, Medtronic Plc, Asahi Kasei Corp, Baxter International Inc, Fresenius Medical Care AG & Co KGaA, B. Braun SE, Angiplast, Becton Dickinson and Co, Utah Medical Products Inc, and Poly Medicure Ltd.
These companies are pursuing various strategic approaches, including geographical expansion, product innovation, partnerships, and mergers and acquisitions. Through these initiatives, market participants seek to develop innovative dialysis solutions, strengthen their product portfolios, respond to evolving patient requirements, expand regional presence, and increase their respective market shares.